Gilead Sciences, Inc. (GILD)
GILD Stock Price Chart
Explore Gilead Sciences, Inc. interactive price chart. Choose custom timeframes to analyze GILD price movements and trends.
GILD Company Profile
Discover essential business fundamentals and corporate details for Gilead Sciences, Inc. (GILD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
22 Jan 1992
Employees
17.60k
Website
https://www.gilead.comCEO
Daniel O'Day
Description
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
GILD Financial Timeline
Browse a chronological timeline of Gilead Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$7.29, while revenue estimate is $7.40bn.
Dividend declared on 15 Jun 2026
A dividend of $0.82 per share was announced, adjusted to $0.82. The dividend was paid on 29 Jun 2026.
Earnings released on 7 May 2026
EPS came in at $2.03 surpassing the estimated $1.91 by +6.28%, while revenue for the quarter reached $6.96bn , beating expectations by +0.67%.
Dividend declared on 13 Mar 2026
A dividend of $0.82 per share was announced, adjusted to $0.82. The dividend was paid on 30 Mar 2026.
Earnings released on 10 Feb 2026
EPS came in at $1.86 surpassing the estimated $1.81 by +2.76%, while revenue for the quarter reached $7.93bn , beating expectations by +3.05%.
Dividend declared on 15 Dec 2025
A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 30 Dec 2025.
Earnings released on 30 Oct 2025
EPS came in at $2.47 surpassing the estimated $2.13 by +15.96%, while revenue for the quarter reached $7.77bn , beating expectations by +4.35%.
Dividend declared on 15 Sept 2025
A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 29 Sept 2025.
Earnings released on 7 Aug 2025
EPS came in at $2.01 surpassing the estimated $1.96 by +2.55%, while revenue for the quarter reached $7.08bn , beating expectations by +1.43%.
Dividend declared on 13 Jun 2025
A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 27 Jun 2025.
Earnings released on 24 Apr 2025
EPS came in at $1.81 surpassing the estimated $1.78 by +1.69%, while revenue for the quarter reached $6.67bn , missing expectations by -2.11%.
Dividend declared on 14 Mar 2025
A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 28 Mar 2025.
Earnings released on 11 Feb 2025
EPS came in at $1.90 surpassing the estimated $1.74 by +9.20%, while revenue for the quarter reached $7.57bn , beating expectations by +5.82%.
Dividend declared on 13 Dec 2024
A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 30 Dec 2024.
Earnings released on 6 Nov 2024
EPS came in at $2.02 surpassing the estimated $1.53 by +32.03%, while revenue for the quarter reached $7.55bn , beating expectations by +7.55%.
Dividend declared on 13 Sept 2024
A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 27 Sept 2024.
Earnings released on 8 Aug 2024
EPS came in at $2.01 surpassing the estimated $1.61 by +24.84%, while revenue for the quarter reached $6.95bn , beating expectations by +3.68%.
Dividend declared on 14 Jun 2024
A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 27 Jun 2024.
Earnings released on 25 Apr 2024
EPS came in at -$1.32 surpassing the estimated -$1.49 by +11.41%, while revenue for the quarter reached $6.69bn , beating expectations by +5.17%.
Dividend declared on 14 Mar 2024
A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 28 Mar 2024.
Earnings released on 6 Feb 2024
EPS came in at $1.72 falling short of the estimated $1.76 by -2.27%, while revenue for the quarter reached $7.12bn , beating expectations by +0.20%.
Dividend declared on 14 Dec 2023
A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 28 Dec 2023.
Earnings released on 7 Nov 2023
EPS came in at $2.29 surpassing the estimated $1.91 by +19.90%, while revenue for the quarter reached $7.05bn , beating expectations by +9.86%.
Dividend declared on 14 Sept 2023
A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 28 Sept 2023.
Earnings released on 3 Aug 2023
EPS came in at $1.34 falling short of the estimated $1.60 by -16.25%, while revenue for the quarter reached $6.60bn , beating expectations by +2.19%.
Dividend declared on 14 Jun 2023
A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 29 Jun 2023.
Earnings released on 27 Apr 2023
EPS came in at $1.37 falling short of the estimated $1.63 by -15.95%, while revenue for the quarter reached $6.35bn , missing expectations by -1.60%.
Dividend declared on 14 Mar 2023
A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 30 Mar 2023.
Earnings released on 2 Feb 2023
EPS came in at $1.67 surpassing the estimated $1.50 by +11.33%, while revenue for the quarter reached $7.39bn , beating expectations by +11.36%.
Dividend declared on 14 Dec 2022
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 29 Dec 2022.
Earnings released on 27 Oct 2022
EPS came in at $1.90 surpassing the estimated $1.44 by +31.94%, while revenue for the quarter reached $7.04bn , beating expectations by +14.87%.
Dividend declared on 14 Sept 2022
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 29 Sept 2022.
Earnings released on 2 Aug 2022
EPS came in at $1.58 surpassing the estimated $1.51 by +4.64%, while revenue for the quarter reached $6.26bn , beating expectations by +6.80%.
Dividend declared on 14 Jun 2022
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 29 Jun 2022.
Earnings released on 28 Apr 2022
EPS came in at $2.12 surpassing the estimated $1.77 by +19.77%, while revenue for the quarter reached $6.59bn , beating expectations by +4.85%.
Dividend declared on 14 Mar 2022
A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 30 Mar 2022.
Earnings released on 1 Feb 2022
EPS came in at $0.69 falling short of the estimated $1.53 by -54.90%, while revenue for the quarter reached $7.24bn , beating expectations by +9.51%.
Dividend declared on 14 Dec 2021
A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 30 Dec 2021.
Earnings released on 28 Oct 2021
EPS came in at $2.65 surpassing the estimated $1.75 by +51.43%, while revenue for the quarter reached $7.42bn , beating expectations by +20.58%.
Dividend declared on 14 Sept 2021
A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 29 Sept 2021.
Earnings released on 29 Jul 2021
EPS came in at $1.87 surpassing the estimated $1.76 by +6.25%, while revenue for the quarter reached $6.22bn , meeting expectations.
GILD Stock Performance
Access detailed GILD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
